What good are whizzy new drugs if the world can’t afford them?

14 June 2024 - Bringing gene therapies and obesity drugs to the masses will require financial innovation too, says Steven Pearson. ...

Read more →

America will struggle to pay for ultra-expensive gene therapies

1 June 2023 - The drugs may force reform to Medicaid. ...

Read more →

Can state prescription drug affordability boards address high cost drug prices?

11 October 2022 - State law makers, like their federal counterparts, are focused on addressing the high and growing cost of ...

Read more →

ICER to develop a California state unsupported price increase report funded by the California Health Care Foundation

3 March 2022 - Expanded funding supports the development of two annual “Unsupported Price Increase” reports specific to drugs identified through ...

Read more →

Making cancer treatments affordable today won’t hurt tomorrow’s innovation

12 May 2021 - Congress is about to debate legislation—the Lower Drug Costs Now Act (H.R.3)—that would give Medicare the ...

Read more →

Many psoriasis patients are paying higher prices than ever at the pharmacy counter

13 August 2020 - Over the past decade, wholesale prices for self-administered psoriasis medicines rose substantially, underscoring the ongoing financial ...

Read more →

The global imperative to make cancer medications affordable

1 May 2020 - The value of any medication is determined by the magnitude of the clinical benefit (improved survival and ...

Read more →

Patients, backed by ‘dark money’ group, get ready to debate Duchenne drug prices. It will not be boring.

24 July 2019 - Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping.  ...

Read more →

Gene therapy was hailed as a revolution. Then came the bill.

7 April 2019 - Cost of new treatments may run into the millions of dollars. ...

Read more →